ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — Cash Flow-to-Debt Ratio
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2025, meaning its operating cash flow of €5.16 Billion could theoretically repay 0% of its total liabilities (€51.00 Billion) in one year. See free cash flow generation of ASPEN PHAR.UN.ADR /1 O.N. to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ASPEN PHAR.UN.ADR /1 O.N. Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for ASPEN PHAR.UN.ADR /1 O.N. across 4 annual periods. Also explore net asset growth rate of ASPEN PHAR.UN.ADR /1 O.N. to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ASPEN PHAR.UN.ADR /1 O.N. (2022–2025)
Year-by-year debt coverage analysis for ASPEN PHAR.UN.ADR /1 O.N.. For market capitalisation and broader financial context, see ASPEN PHAR.UN.ADR /1 O.N. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €5.16 Billion | €51.00 Billion | ▼ -11.9% |
| 2024 | 0.11x | €6.22 Billion | €54.20 Billion | ▼ 0.0% |
| 2023 | 0.11x | €5.52 Billion | €48.05 Billion | ▼ -13.6% |
| 2022 | 0.13x | €5.37 Billion | €40.43 Billion | — |